STOCK TITAN

Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Revvity (NYSE: RVTY) has announced its participation in the 7th Annual Evercore ISI HealthCONx Conference scheduled for December 3, 2024, at 8:20 a.m. ET in Coral Gables, FL. President and CEO Prahlad Singh will present an update on the company and its strategic priorities. The presentation will be accessible through a live audio webcast on the company's website's Events section, with a replay available on the Revvity Investor Relations website for at least 30 days following the event.

Revvity (NYSE: RVTY) ha annunciato la sua partecipazione alla 7ª Conferenza Annuale Evercore ISI HealthCONx programmata per il 3 dicembre 2024, alle 8:20 del mattino ET a Coral Gables, FL. Il Presidente e CEO Prahlad Singh presenterà un aggiornamento sull'azienda e le sue priorità strategiche. La presentazione sarà accessibile tramite un webcast audio in diretta nella sezione Eventi del sito web dell'azienda, con una registrazione disponibile sul sito web di Revvity Investor Relations per almeno 30 giorni dopo l'evento.

Revvity (NYSE: RVTY) ha anunciado su participación en la 7ª Conferencia Anual Evercore ISI HealthCONx programada para el 3 de diciembre de 2024, a las 8:20 a.m. ET en Coral Gables, FL. El presidente y CEO Prahlad Singh presentará una actualización sobre la empresa y sus prioridades estratégicas. La presentación será accesible a través de una transmisión en vivo de audio en la sección de Eventos del sitio web de la empresa, con una repetición disponible en el sitio web de Revvity Investor Relations durante al menos 30 días después del evento.

Revvity (NYSE: RVTY)는 2024년 12월 3일 오전 8시 20분 ET에 플로리다주 코럴 게이블스에서 열리는 제7회 연례 Evercore ISI HealthCONx 컨퍼런스에 참여할 것이라고 발표했습니다. Prahlad Singh 사장 겸 CEO가 회사 및 전략적 우선 사항에 대한 업데이트를 발표할 예정입니다. 발표는 회사 웹사이트의 이벤트 섹션에서 생중계 오디오 웹캐스트를 통해 접근 가능하며, 이벤트 이후 30일 이상 Revvity Investor Relations 웹사이트에서 다시 볼 수 있습니다.

Revvity (NYSE: RVTY) a annoncé sa participation à la 7ème Conférence Annuelle Evercore ISI HealthCONx prévue pour le 3 décembre 2024 à 8h20 ET à Coral Gables, FL. Le Président et CEO Prahlad Singh fera une mise à jour sur l'entreprise et ses priorités stratégiques. La présentation sera accessible via un webcast audio en direct dans la section Événements du site web de l'entreprise, avec un enregistrement accessible sur le site de Revvity Investor Relations pendant au moins 30 jours après l'événement.

Revvity (NYSE: RVTY) hat seine Teilnahme an der 7. jährlichen Evercore ISI HealthCONx Konferenz angekündigt, die für den 3. Dezember 2024 um 8:20 Uhr ET in Coral Gables, FL, angesetzt ist. Präsident und CEO Prahlad Singh wird ein Update über das Unternehmen und seine strategischen Prioritäten präsentieren. Die Präsentation wird über einen Live-Audio-Webcast im Veranstaltungsbereich der Unternehmenswebsite zugänglich sein, mit einer Aufzeichnung, die für mindestens 30 Tage nach der Veranstaltung auf der Website Revvity Investor Relations verfügbar ist.

Positive
  • None.
Negative
  • None.

WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. (NYSE: RVTY), will present at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, December 3, 2024, at 8:20 a.m. ET in Coral Gables, FL.

Prahlad Singh, president and chief executive officer, will provide an update on the Company and its strategic priorities. To register, click here.

A live audio webcast will be available on the Events section of the Company’s website. A replay of the presentation will be posted on the Revvity Investor Relations website after the event and will be available for at least 30 days.

About Revvity

At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.

With 2023 revenue of more than $2.7 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.

Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.

Media Relations:

Chet Murray

(781) 462-5126

chet.murray@revvity.com

Investor Relations:

Steve Willoughby

steve.willoughby@revvity.com

Source: Revvity

FAQ

When is Revvity (RVTY) presenting at the Evercore ISI HealthCONx Conference 2024?

Revvity (RVTY) will present at the conference on Tuesday, December 3, 2024, at 8:20 a.m. ET in Coral Gables, FL.

How can I watch Revvity's (RVTY) presentation at the 2024 HealthCONx Conference?

You can watch the presentation through a live audio webcast available on the Events section of Revvity's website, with a replay available on their Investor Relations website for at least 30 days after the event.

What will be discussed in Revvity's (RVTY) presentation at the 2024 HealthCONx Conference?

President and CEO Prahlad Singh will provide an update on the company and its strategic priorities during the presentation.

How long will Revvity's (RVTY) HealthCONx Conference presentation replay be available?

The replay of the presentation will be available on Revvity's Investor Relations website for at least 30 days after the event.

Revvity, Inc.

NYSE:RVTY

RVTY Rankings

RVTY Latest News

RVTY Stock Data

13.62B
121.35M
0.29%
92.08%
3.36%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States of America
WALTHAM